Exact Mass: 345.2515

Exact Mass Matches: 345.2515

Found 223 metabolites which its exact mass value is equals to given mass value 345.2515, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Himbacine

(+)-Himbacine

C22H35NO2 (345.2668)


A piperidine alkaloid that is decahydronaphtho[2,3-c]furan-1(3H)-one substituted by a methyl group at position 3 and a 2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl group at position 4. It has been isolated from the bark of Australian magnolias. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics relative retention time with respect to 9-anthracene Carboxylic Acid is 0.814 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.809

   

Eicosapentaenoyl Ethanolamide

(5Z,8Z,11Z,14Z,17Z)-N-(2-hydroxyethyl)icosa-5,8,11,14,17-pentaenamide

C22H35NO2 (345.2668)


Eicosapentaenoyl Ethanolamide (EPEA) is an endogenous fatty acid amide. EPEA is metabolized by fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA), the latter of which has more specificity toward PEA over other fatty acid amides. DHEA and eicosapentaenoyl ethanolamide (EPEA) bind to the CB1 receptor in rat brains.23 DHA levels in the mouse brain have been shown to inversely affect the levels of 2AG. Eicosapentaenoyl Ethanolamide (EPEA) is an endogenous fatty acid amide.

   

3-hydroxyundecanoyl carnitine

3-[(3-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


3-Hydroxyundecanoyl carnitine is an acylcarnitine. More specifically, it is an 3-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxyundecanoyl carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyundecanoyl carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Sebacoyl-L-carnitine

3-[(9-Carboxynonanoyl)oxy]-4-(trimethylammonio)butanoic acid

C17H31NO6 (345.2151)


Sebacoyl-L-carnitine is an acylcarnitine. More specifically, it is an sebacic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Sebacoyl-L-carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Sebacoyl-L-carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylnonanedioylcarnitine

3-[(8-carboxy-3-methyloctanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO6 (345.2151)


3-Methylnonanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-methylnonanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylnonanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylnonanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Hydroxyundecanoylcarnitine

3-[(8-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


8-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 8-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 8-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxyundecanoylcarnitine

3-[(5-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


5-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Hydroxyundecanoylcarnitine

3-[(2-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


2-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 2-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Hydroxyundecanoylcarnitine

3-[(9-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


9-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 9-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 9-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyundecanoylcarnitine

3-[(6-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


6-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyundecanoylcarnitine

3-[(7-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


7-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Hydroxyundecanoylcarnitine

3-[(10-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


10-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 10-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 10-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 10-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Hydroxyundecanoylcarnitine

3-[(4-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


4-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Nitroxystearic acid

2-(3-Carboxypropyl)-2-tridecyl-4,4-dimethyl-3-oxazolidinyloxyl

C18H35NO5 (345.2515)


   

2-[4-[4-(4-Carbamimidoylphenyl)piperazin-1-yl]piperidin-1-yl]acetic acid

4-(4-(4-(Aminoiminomethyl)phenyl)-1-piperazinyl)-piperidineacetic acid hydrochloride trihydrate

C18H27N5O2 (345.2165)


   

Himbacine

4-[2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3H-naphtho[2,3-c]furan-1-one

C22H35NO2 (345.2668)


   

1-Piperidinepropanol, alpha-cyclohexyl-4-(3-hydroxyphenyl)-3,4-dimethyl-

1-(3-Hydroxy-3-cyclohexylpropyl)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidine

C22H35NO2 (345.2668)


   

4-Phenyl-1-(3-(tetrahydro-2-furyl)propyl)isonipecotic acid ethyl ester

4-Phenyl-1-(3-(tetrahydro-2-furyl)propyl)isonipecotic acid ethyl ester

C21H31NO3 (345.2304)


   

N-(2-Hydroxyethyl)icosa-2,4,6,8,10-pentaenamide

N-(2-Hydroxyethyl)icosa-2,4,6,8,10-pentaenimidate

C22H35NO2 (345.2668)


   

Broussonetinine B

Broussonetinine B

C18H35NO5 (345.2515)


   

Dihydroatisine

F-Dihydroatisine

C22H35NO2 (345.2668)


   
   
   

SCHEMBL16280593

SCHEMBL16280593

C15H31N5O4 (345.2376)


   

Dehydrodictysine

Dehydrodictysine

C21H31NO3 (345.2304)


   
   

Daphnezomine M

Daphnezomine M

C22H35NO2 (345.2668)


   

XLR11 N-(4-hydroxypentyl) metabolite

XLR11 N-(4-hydroxypentyl) metabolite

C21H28FNO2 (345.2104)


   
   

paxdaphnidine B

paxdaphnidine B

C22H35NO2 (345.2668)


   

batzellaside C

batzellaside C

C19H39NO4 (345.2879)


   

Samandaridin|Samandaridine

Samandaridin|Samandaridine

C21H31NO3 (345.2304)


   

asperparaline B

asperparaline B

C19H27N3O3 (345.2052)


   
   
   

curvularide A

curvularide A

C18H35NO5 (345.2515)


   

Kurchiphyllamine

Kurchiphyllamine

C22H35NO2 (345.2668)


   

asperparaline C

asperparaline C

C19H27N3O3 (345.2052)


   

paxdaphnine B

paxdaphnine B

C21H31NO3 (345.2304)


   
   

3-(3-methyl-5H-dibenzo[a,d]cyclohepten-5-yloxy)-tropane|5-Tropyloxy-3-methyl-dibenzo-1.3.5-cycloheptatrien|5-Tropyloxy-3-methyldibenzo-1,3,5-cycloheptatrien

3-(3-methyl-5H-dibenzo[a,d]cyclohepten-5-yloxy)-tropane|5-Tropyloxy-3-methyl-dibenzo-1.3.5-cycloheptatrien|5-Tropyloxy-3-methyldibenzo-1,3,5-cycloheptatrien

C24H27NO (345.2093)


   

20-Oxime-(17alphaOH)-17-Hydroxypregn-4-ene-3,20-dione

20-Oxime-(17alphaOH)-17-Hydroxypregn-4-ene-3,20-dione

C21H31NO3 (345.2304)


   

aspergillimide|asperparaline A

aspergillimide|asperparaline A

C19H27N3O3 (345.2052)


   

calyciphylline F

calyciphylline F

C22H35NO2 (345.2668)


   

(19R)-16beta,19-dihydroxy-(5beta,10alpha)-3-aza-3alpha,19-cyclo-4a-homo-pregnan-21-oic acid 16-lactone|Cycloneosamandaridin

(19R)-16beta,19-dihydroxy-(5beta,10alpha)-3-aza-3alpha,19-cyclo-4a-homo-pregnan-21-oic acid 16-lactone|Cycloneosamandaridin

C21H31NO3 (345.2304)


   

alanyllysyllysine

alanyllysyllysine

C15H31N5O4 (345.2376)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

lysylalanyllysine

lysylalanyllysine

C15H31N5O4 (345.2376)


   

MLS001074064-01!Bentyl

MLS001074064-01!Bentyl

C19H36ClNO2 (345.2434)


   

XLR11 N-(4-HYDROXYPENTYL)

XLR11 N-(4-HYDROXYPENTYL)

C21H28FNO2 (345.2104)


   
   
   
   
   
   
   
   
   
   
   
   
   

(+)-Samandaridine

(+)-Samandaridine

C21H31NO3 (345.2304)


   

Isocycloneosamandaridine

Isocycloneosamandaridine

C21H31NO3 (345.2304)


   

Anandamide (20:5, n-3)

N-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-ethanolamine

C22H35NO2 (345.2668)


   

CAR 10:1;O2

3-[(9-carboxynonanoyl)oxy]-4-(trimethylammonio)butanoate;sebacoylcarnitine

C17H31NO6 (345.2151)


   

NAE 20:5

N-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-ethanolamine

C22H35NO2 (345.2668)


   
   

TERT-BUTYL 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)INDOLINE-1-CARBOXYLATE

TERT-BUTYL 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)INDOLINE-1-CARBOXYLATE

C19H28BNO4 (345.2111)


   

1-(3,7-dimethyloctyl)-1-prop-2-enyl-3,4,5,6-tetrahydro-2H-pyridine bro mide

1-(3,7-dimethyloctyl)-1-prop-2-enyl-3,4,5,6-tetrahydro-2H-pyridine bro mide

C18H36BrN (345.2031)


   

dehydroabietylamine acetate

dehydroabietylamine acetate

C22H35NO2 (345.2668)


   

6-AMINO-3-(4-METHYL-PIPERAZIN-1-YLMETHYL)-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

6-AMINO-3-(4-METHYL-PIPERAZIN-1-YLMETHYL)-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C18H27N5O2 (345.2165)


   
   

Dicyclomine hydrochloride

Dicyclomine hydrochloride

C19H36ClNO2 (345.2434)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent Dicyclomine hydrochloride is a potent and orally active muscarinic cholinergic receptors antagonist. Dicyclomine hydrochloride shows high affinity for muscarinic M1 receptor subtype (Ki=5.1 nM) and M2 receptor subtype (Ki=54.6 nM) in brush-border membrane and basal plasma membranes, respectively[1]. Dicyclomine is an antispasmodic agent and relieves smooth muscle spasm of the gastrointestinal tract in vivo[2].

   

tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate

tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate

C19H28BNO4 (345.2111)


   

7-Ethano-1H-isoindole-1, 3(2H)-dion, 2-(2-ethylhexyl)-3a,4,7,7a-tetrahydro-4-methyl-7-(1-methylethy4

7-Ethano-1H-isoindole-1, 3(2H)-dion, 2-(2-ethylhexyl)-3a,4,7,7a-tetrahydro-4-methyl-7-(1-methylethy4

C22H35NO2 (345.2668)


   

4-(3-(Piperidin-1-yl)propoxy)phenylboronic acid, pinacol ester

4-(3-(Piperidin-1-yl)propoxy)phenylboronic acid, pinacol ester

C20H32BNO3 (345.2475)


   

tert-Butyl 4-(1-benzylpyrrolidin-3-yl)piperazine-1-carboxylate

tert-Butyl 4-(1-benzylpyrrolidin-3-yl)piperazine-1-carboxylate

C20H31N3O2 (345.2416)


   

N-BOC-isoindoline-4-boronic acid, pinacol ester

N-BOC-isoindoline-4-boronic acid, pinacol ester

C19H28BNO4 (345.2111)


   

Ethyl 3-Oxo-4-aza-5α-androst-1-ene-17β-carboxylate

Ethyl 3-Oxo-4-aza-5α-androst-1-ene-17β-carboxylate

C21H31NO3 (345.2304)


   

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindoline-2-carboxylate

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindoline-2-carboxylate

C19H28BNO4 (345.2111)


   

N-(2-hydroxyethyl)-N-(2-hydroxytetradecyl)beta-alanine

N-(2-hydroxyethyl)-N-(2-hydroxytetradecyl)beta-alanine

C19H39NO4 (345.2879)


   

N1,N4-Bis-Boc-spermidine

N1,N4-Bis-Boc-spermidine

C17H35N3O4 (345.2627)


   

N1,N5-Bis-Boc-spermidine

N1,N5-Bis-Boc-spermidine

C17H35N3O4 (345.2627)


   

Alanyl-lysyl-lysine

Alanyl-lysyl-lysine

C15H31N5O4 (345.2376)


   

4-(1,3-benzodioxol-5-ylmethyl)-N-cyclohexylpiperazine-1-carboxamide

4-(1,3-benzodioxol-5-ylmethyl)-N-cyclohexylpiperazine-1-carboxamide

C19H27N3O3 (345.2052)


   

Diprenylphlorisovalerophenone

Diprenylphlorisovalerophenone

C21H29O4- (345.2066)


   

4,6--Diprenylphlormethylbutanophenone

4,6--Diprenylphlormethylbutanophenone

C21H29O4- (345.2066)


   

3-Methylnonanedioylcarnitine

3-Methylnonanedioylcarnitine

C17H31NO6 (345.2151)


   

8-Hydroxyundecanoylcarnitine

8-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

5-Hydroxyundecanoylcarnitine

5-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

2-Hydroxyundecanoylcarnitine

2-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

9-Hydroxyundecanoylcarnitine

9-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

6-Hydroxyundecanoylcarnitine

6-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

7-Hydroxyundecanoylcarnitine

7-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

4-Hydroxyundecanoylcarnitine

4-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

N-eicosapentaenoylethanolamine

N-eicosapentaenoylethanolamine

C22H35NO2 (345.2668)


   

10-Hydroxyundecanoylcarnitine

10-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

(+)-Himbacine

(+)-Himbacine

C22H35NO2 (345.2668)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics

   

(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoate

(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoate

C22H33O3- (345.243)


A polyunsaturated fatty acid anion that is the conjugate base of (13R)-hydroxy-(7Z,10Z,14E,16Z,19Z)-docosapentaenoic acid, arising from deprotonation of the carboxylic acid group; major species at pH 7.3. It is an intermediate in 13-series resolvins biosynthesis from DPA (omega-3).

   

(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]propanoyl]amino]hexanoic Acid

(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]propanoyl]amino]hexanoic Acid

C15H31N5O4 (345.2376)


   

1-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)pyrrolidine-2,5-dione

1-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)pyrrolidine-2,5-dione

C19H27N3O3 (345.2052)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

4-[2-(2,6-Dimethyl-1-piperidinyl)-2-oxoethyl]-1-methyl-5-pyrrolo[3,2-b]pyrrolecarboxylic acid ethyl ester

4-[2-(2,6-Dimethyl-1-piperidinyl)-2-oxoethyl]-1-methyl-5-pyrrolo[3,2-b]pyrrolecarboxylic acid ethyl ester

C19H27N3O3 (345.2052)


   
   

2-phenyl-N-(3-(piperidin-1-yl)propyl)quinolin-4-amine

2-phenyl-N-(3-(piperidin-1-yl)propyl)quinolin-4-amine

C23H27N3 (345.2205)


   

2-(2-methoxyethyl)-7-[oxo-(4-propyl-1-piperazinyl)methyl]-3H-isoindol-1-one

2-(2-methoxyethyl)-7-[oxo-(4-propyl-1-piperazinyl)methyl]-3H-isoindol-1-one

C19H27N3O3 (345.2052)


   

4-methyl-N-(3-morpholin-4-ylpropyl)-3-(2-oxopyrrolidin-1-yl)benzamide

4-methyl-N-(3-morpholin-4-ylpropyl)-3-(2-oxopyrrolidin-1-yl)benzamide

C19H27N3O3 (345.2052)


   

[1-(Cyclohexylmethyl)-3-piperidinyl]-(3,4-dimethoxyphenyl)methanone

[1-(Cyclohexylmethyl)-3-piperidinyl]-(3,4-dimethoxyphenyl)methanone

C21H31NO3 (345.2304)


   

(7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-7,10,13,16-tetraenoate

(7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-7,10,13,16-tetraenoate

C22H33O3- (345.243)


   

(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosa-4,7,10,13,16-pentaenoate

(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosa-4,7,10,13,16-pentaenoate

C22H33O3- (345.243)


   

(7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-7,10,13-trienoate

(7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-7,10,13-trienoate

C22H33O3- (345.243)


   

(7Z,10Z)-12-{3-[(2Z,5Z)-octa-2,5-dien-1-yl]oxiran-2-yl}dodeca-7,10-dienoate

(7Z,10Z)-12-{3-[(2Z,5Z)-octa-2,5-dien-1-yl]oxiran-2-yl}dodeca-7,10-dienoate

C22H33O3- (345.243)


   

(7Z)-9-{3-[(2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl]oxiran-2-yl}non-7-enoate

(7Z)-9-{3-[(2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl]oxiran-2-yl}non-7-enoate

C22H33O3- (345.243)


   
   
   
   
   

2-{[1,1-bi(cyclohexyl)-1-ylcarbonyl]oxy}-N,N-diethylethanaminium chloride

2-{[1,1-bi(cyclohexyl)-1-ylcarbonyl]oxy}-N,N-diethylethanaminium chloride

C19H36ClNO2 (345.2434)


   

(2S,3R)-2-(hydroxymethyl)-6-(1-oxopropyl)-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2S,3R)-2-(hydroxymethyl)-6-(1-oxopropyl)-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C19H27N3O3 (345.2052)


   

(2S,3S)-2-(hydroxymethyl)-6-(1-oxopropyl)-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2S,3S)-2-(hydroxymethyl)-6-(1-oxopropyl)-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C19H27N3O3 (345.2052)


   
   
   
   
   
   
   
   
   
   

12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodecanoate

12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodecanoate

C18H33O6- (345.2277)


   

Sebacoyl-L-carnitine, analytical standard

Sebacoyl-L-carnitine, analytical standard

C17H31NO6 (345.2151)


   

(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosa-8,10,13,16,19-pentaenoate

(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosa-8,10,13,16,19-pentaenoate

C22H33O3- (345.243)


   

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosa-4,7,10,12,16-pentaenoate

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosa-4,7,10,12,16-pentaenoate

C22H33O3- (345.243)


   

(11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydodecanoate

(11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydodecanoate

C18H33O6- (345.2277)


   

N-(omega-hydroxyacyl)-sphingosine

N-(omega-hydroxyacyl)-sphingosine

C19H39NO4 (345.2879)


   

Diamino-(carboxymethyl)-[3-(dodecanoylamino)propyl]azanium

Diamino-(carboxymethyl)-[3-(dodecanoylamino)propyl]azanium

C17H37N4O3+ (345.2866)


   

(5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine

(5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine

C22H35NO2 (345.2668)


An N-acylethanolamine 20:5 that is the ethanolamide of (5Z,8Z,11Z,14Z17Z)-eicosapentaenoic acid.

   

2-[4-[4-(4-Carbamimidoylphenyl)piperazin-1-yl]piperidin-1-yl]acetic acid

2-[4-[4-(4-Carbamimidoylphenyl)piperazin-1-yl]piperidin-1-yl]acetic acid

C18H27N5O2 (345.2165)


   

O-sebacoylcarnitine

O-sebacoylcarnitine

C17H31NO6 (345.2151)


An O-acylcarnitine having sebacoyl as the acyl substituent.

   

3-hydroxyundecanoyl carnitine

3-hydroxyundecanoyl carnitine

C18H35NO5 (345.2515)


   

(7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoate

(7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3

   

(7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoate

(7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoate

(7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoate

(7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoate

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoate

C22H33O3 (345.243)


A hydroxydocosapentaenoate that is the conjugate base of (4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoic acid, arising from deprotonation of the carboxy group; major species at pH 7.3.

   

(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosapentaenoate

(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosapentaenoate

C22H33O3 (345.243)


A hydroxydocosahexaenoate that is the conjugate base of (8E,10Z,13Z,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#20(1-)

ascr#20(1-)

C18H33O6 (345.2277)


Conjugate base of ascr#20

   

(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoate

(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

oscr#20(1-)

oscr#20(1-)

C18H33O6 (345.2277)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#20, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   
   

NA-PABA 14:1(9Z)

NA-PABA 14:1(9Z)

C21H31NO3 (345.2304)


   

Eicosapentenoyl-EA

Eicosapentenoyl-EA

C22H35NO2 (345.2668)


   
   
   
   
   

LY255582

LY255582

C22H35NO2 (345.2668)


LY255582 is a pan-opioid antagonist and has high affinity for mu, delta, and kappa receptors (Ki: 0.4 nM, 5.2, 2.0 nM respectively). LY255582 can decrease food intake and body weight. LY255582 can be used for the research of obesity[1][2][3][4].

   

3-{14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl}propanoic acid

3-{14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl}propanoic acid

C22H35NO2 (345.2668)


   

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

C18H35NO5 (345.2515)


   

(7z)-5-methoxy-8-methyl-11-(6-methylhept-5-en-2-yl)-13-oxa-2-azatricyclo[8.2.1.0⁴,¹²]trideca-2,4(12),7-trien-3-ol

(7z)-5-methoxy-8-methyl-11-(6-methylhept-5-en-2-yl)-13-oxa-2-azatricyclo[8.2.1.0⁴,¹²]trideca-2,4(12),7-trien-3-ol

C21H31NO3 (345.2304)


   

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

C18H35NO5 (345.2515)


   

methyl 3-[(1s,2s,3r,7s,10r,12r,13s)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

methyl 3-[(1s,2s,3r,7s,10r,12r,13s)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

C22H35NO2 (345.2668)


   

13-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

13-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

C18H35NO5 (345.2515)


   

(1s,2s,6r,7s,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

(1s,2s,6r,7s,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

C22H35NO2 (345.2668)


   

3-[(2r,5s)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[(2r,5s)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C19H27N3O3 (345.2052)


   

(1s,2s,4r,6r,7r,10r,11s)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

(1s,2s,4r,6r,7r,10r,11s)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

C22H35NO2 (345.2668)


   

(1's,3s,3's,7's)-1,4',4',14'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,13'-trione

(1's,3s,3's,7's)-1,4',4',14'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,13'-trione

C19H27N3O3 (345.2052)


   

methyl 3-{13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl}propanoate

methyl 3-{13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl}propanoate

C22H35NO2 (345.2668)


   

(6e)-2-(dimethylamino)-1-(4-hydroxyphenyl)-8,10-dimethyldodec-6-en-3-one

(6e)-2-(dimethylamino)-1-(4-hydroxyphenyl)-8,10-dimethyldodec-6-en-3-one

C22H35NO2 (345.2668)


   

(1s,2s,4s,6r,7s,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

(1s,2s,4s,6r,7s,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

C22H35NO2 (345.2668)


   

methyl 5-ethyl-2-(hydroxymethyl)-6-azapentacyclo[9.5.1.0¹,⁵.0²,⁸.0¹⁴,¹⁷]heptadec-11(17)-ene-15-carboxylate

methyl 5-ethyl-2-(hydroxymethyl)-6-azapentacyclo[9.5.1.0¹,⁵.0²,⁸.0¹⁴,¹⁷]heptadec-11(17)-ene-15-carboxylate

C21H31NO3 (345.2304)


   

(1'r,3s,3's,7's,12's)-13'-hydroxy-1,4',4',12'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-2,5-dione

(1'r,3s,3's,7's,12's)-13'-hydroxy-1,4',4',12'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-2,5-dione

C19H27N3O3 (345.2052)


   

methyl 3-[(1r,2r,3s,10s,12s,13r)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

methyl 3-[(1r,2r,3s,10s,12s,13r)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

C22H35NO2 (345.2668)


   

(2e,7e)-tetradeca-2,7-dien-1-yl 4-amino-3-hydroxybenzoate

(2e,7e)-tetradeca-2,7-dien-1-yl 4-amino-3-hydroxybenzoate

C21H31NO3 (345.2304)


   

3-[(2s,5r)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[(2s,5r)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C19H27N3O3 (345.2052)


   

(2r,3s,4s,6s)-2-(hydroxymethyl)-6-(2-hydroxytridecyl)piperidine-3,4-diol

(2r,3s,4s,6s)-2-(hydroxymethyl)-6-(2-hydroxytridecyl)piperidine-3,4-diol

C19H39NO4 (345.2879)


   

(2e,4r,5s,6s,8r)-4,5,8-trihydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-4,6-dimethyldec-2-enimidic acid

(2e,4r,5s,6s,8r)-4,5,8-trihydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-4,6-dimethyldec-2-enimidic acid

C18H35NO5 (345.2515)


   

(2s,5s,10r,13s,14s,17s,18s)-4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-14,18-diol

(2s,5s,10r,13s,14s,17s,18s)-4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-14,18-diol

C21H31NO3 (345.2304)


   

(3s,3ar,4r,8ar,9as)-4-[(1e)-2-[(2s,6r)-1,6-dimethylpiperidin-2-yl]ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one

(3s,3ar,4r,8ar,9as)-4-[(1e)-2-[(2s,6r)-1,6-dimethylpiperidin-2-yl]ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one

C22H35NO2 (345.2668)


   

13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

C18H35NO5 (345.2515)


   

3-[(2r,5r)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[(2r,5r)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C19H27N3O3 (345.2052)


   

5-hydroxy-4',4',12',14'-tetramethyl-4h-9',14'-diazaspiro[pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,13'-dione

5-hydroxy-4',4',12',14'-tetramethyl-4h-9',14'-diazaspiro[pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,13'-dione

C19H27N3O3 (345.2052)


   

2-(dimethylamino)-1-(4-hydroxyphenyl)-8,10-dimethyldodec-6-en-3-one

2-(dimethylamino)-1-(4-hydroxyphenyl)-8,10-dimethyldodec-6-en-3-one

C22H35NO2 (345.2668)


   

4,5,8-trihydroxy-n-(1-hydroxy-3-methylpentan-2-yl)-4,6-dimethyldec-2-enimidic acid

4,5,8-trihydroxy-n-(1-hydroxy-3-methylpentan-2-yl)-4,6-dimethyldec-2-enimidic acid

C18H35NO5 (345.2515)


   

(3e,7e)-n-(3,4-dihydroxybutyl)-2,6,9-trihydroxy-4,8-dimethylundeca-3,7-dienimidic acid

(3e,7e)-n-(3,4-dihydroxybutyl)-2,6,9-trihydroxy-4,8-dimethylundeca-3,7-dienimidic acid

C17H31NO6 (345.2151)


   

13'-hydroxy-1,4',4',12'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-2,5-dione

13'-hydroxy-1,4',4',12'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-2,5-dione

C19H27N3O3 (345.2052)


   

13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

C22H35NO2 (345.2668)


   

3-[3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C19H27N3O3 (345.2052)


   

3-[(2s,5s)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[(2s,5s)-3,6-dihydroxy-5-(2-methylpropyl)-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C19H27N3O3 (345.2052)


   

4-[(1e)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one

4-[(1e)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one

C22H35NO2 (345.2668)


   

n-(3,4-dihydroxybutyl)-2,8,9-trihydroxy-4,8-dimethylundeca-3,6-dienimidic acid

n-(3,4-dihydroxybutyl)-2,8,9-trihydroxy-4,8-dimethylundeca-3,6-dienimidic acid

C17H31NO6 (345.2151)


   

(1'r,3s,3's,7's,12's)-5-hydroxy-4',4',12',14'-tetramethyl-4h-9',14'-diazaspiro[pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,13'-dione

(1'r,3s,3's,7's,12's)-5-hydroxy-4',4',12',14'-tetramethyl-4h-9',14'-diazaspiro[pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,13'-dione

C19H27N3O3 (345.2052)


   

(2s)-n-[(2s)-1-(acetyloxy)-3-(1h-indol-3-yl)propan-2-yl]-3-methyl-2-(methylamino)butanimidic acid

(2s)-n-[(2s)-1-(acetyloxy)-3-(1h-indol-3-yl)propan-2-yl]-3-methyl-2-(methylamino)butanimidic acid

C19H27N3O3 (345.2052)


   

13-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

13-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

C18H35NO5 (345.2515)


   

1,4',4',14'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,13'-trione

1,4',4',14'-tetramethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,13'-trione

C19H27N3O3 (345.2052)


   

3-[(1s,2r,3r,7r,10s,11r,13s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoic acid

3-[(1s,2r,3r,7r,10s,11r,13s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoic acid

C22H35NO2 (345.2668)


   

({[(3s)-6-amino-3-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyhexylidene]amino}(methyl)amino)acetic acid

({[(3s)-6-amino-3-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyhexylidene]amino}(methyl)amino)acetic acid

C15H31N5O4 (345.2376)


   

3-[(1r,2r,7s,10r,13r,14s)-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl]propanoic acid

3-[(1r,2r,7s,10r,13r,14s)-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl]propanoic acid

C22H35NO2 (345.2668)


   

n-(3,4-dihydroxybutyl)-2,6,9-trihydroxy-4,8-dimethylundeca-3,7-dienimidic acid

n-(3,4-dihydroxybutyl)-2,6,9-trihydroxy-4,8-dimethylundeca-3,7-dienimidic acid

C17H31NO6 (345.2151)


   

3-[(1s,2r,7r,10s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoic acid

3-[(1s,2r,7r,10s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoic acid

C22H35NO2 (345.2668)


   

(3e,6e)-n-(3,4-dihydroxybutyl)-2,8,9-trihydroxy-4,8-dimethylundeca-3,6-dienimidic acid

(3e,6e)-n-(3,4-dihydroxybutyl)-2,8,9-trihydroxy-4,8-dimethylundeca-3,6-dienimidic acid

C17H31NO6 (345.2151)


   

13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

C18H35NO5 (345.2515)


   

[({6-amino-3-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1-hydroxyhexylidene}amino)(methyl)amino]acetic acid

[({6-amino-3-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1-hydroxyhexylidene}amino)(methyl)amino]acetic acid

C15H31N5O4 (345.2376)


   

methyl (1r,2r,5s,8s,14r,15r)-5-ethyl-2-(hydroxymethyl)-6-azapentacyclo[9.5.1.0¹,⁵.0²,⁸.0¹⁴,¹⁷]heptadec-11(17)-ene-15-carboxylate

methyl (1r,2r,5s,8s,14r,15r)-5-ethyl-2-(hydroxymethyl)-6-azapentacyclo[9.5.1.0¹,⁵.0²,⁸.0¹⁴,¹⁷]heptadec-11(17)-ene-15-carboxylate

C21H31NO3 (345.2304)


   

tetradeca-2,7-dien-1-yl 4-amino-3-hydroxybenzoate

tetradeca-2,7-dien-1-yl 4-amino-3-hydroxybenzoate

C21H31NO3 (345.2304)


   

12-hydroxy-12-(hydroxymethyl)-5,7-dimethyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecan-11-one

12-hydroxy-12-(hydroxymethyl)-5,7-dimethyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecan-11-one

C21H31NO3 (345.2304)